Opgen Inc. Reports Board Changes and Officer Compensation Updates
Ticker: CFOR · Form: 8-K · Filed: Apr 17, 2024 · CIK: 1293818
| Field | Detail |
|---|---|
| Company | Opgen Inc (CFOR) |
| Form Type | 8-K |
| Filed Date | Apr 17, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $406,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-of-directors, executive-compensation, corporate-governance
TL;DR
Opgen Inc. filed an 8-K on 4/11/24 about board changes and exec comp. Watch for details.
AI Summary
On April 11, 2024, Opgen Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the election of new directors and potential adjustments to compensatory arrangements for certain officers. Specific details regarding the individuals appointed or the exact nature of the compensatory changes were not elaborated upon in the provided text.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect the company's future direction and performance.
Key Numbers
- 001-37367 — SEC File Number (Identifies the company's filing with the SEC.)
- 06-1614015 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Opgen Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Rockville, MD (location) — Principal executive offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors but does not specify the names of the individuals elected or any departures.
What are the details of the compensatory arrangements for certain officers?
The filing mentions adjustments to compensatory arrangements but does not provide specific details on the nature or value of these arrangements.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 11, 2024.
What is Opgen Inc.'s principal executive office address?
Opgen Inc.'s principal executive offices are located at 9717 Key West Ave, Suite 100, Rockville, MD 20850.
What is the SIC code for Opgen Inc.?
The Standard Industrial Classification (SIC) code for Opgen Inc. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
Filing Stats: 864 words · 3 min read · ~3 pages · Grade level 8.5 · Accepted 2024-04-16 19:22:29
Key Financial Figures
- $406,000 — r. Lazar shall be paid a base salary of $406,000 per annum, which shall be deferred and
Filing Documents
- opgen_8k.htm (8-K) — 28KB
- opgen_ex10-1.htm (EX-10.1) — 60KB
- 0001829126-24-002584.txt ( ) — 277KB
- opgn-20240411.xsd (EX-101.SCH) — 3KB
- opgn-20240411_lab.xml (EX-101.LAB) — 33KB
- opgn-20240411_pre.xml (EX-101.PRE) — 22KB
- opgen_8k_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Employment Agreement, dated April 11, 2024, by and between the Company and David Lazar. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OpGen, Inc. Date: April 16, 2024 By: /s/ David Lazar David Lazar Chief Executive Officer 2